Airain Ltd’s Epizyme, Inc EPZM Stock Holding History

Airain Ltd’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-27,519	Closed	-$334K	–	964
2016 Q1	$334K	Buy	+27,519	New	+$278K	0.02%	542

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Airain Ltd's EPZM Position: Q2 2016 in Review

Airain Ltd sold out of Epizyme, Inc (EPZM) in Q2 2016, closing a stake of 27,519 shares — an estimated $334K sold.

Airain Ltd first reported a position in EPZM in Q1 2016 and held it in 1 quarter. The position peaked at $334K in Q1 2016. 99 funds tracked by Wall St. Rank hold EPZM as of Q2 2016.

Airain Ltd reported no remaining Epizyme, Inc position as of Q2 2016 after selling out during the quarter.
Airain Ltd sold 27,519 Epizyme, Inc shares in Q2 2016, an estimated $334K.
Airain Ltd first reported a position in Epizyme, Inc in Q1 2016 and held it in 1 quarter.
Airain Ltd's Epizyme, Inc position peaked at $334K in Q1 2016.
99 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.